Frequently Asked Questions B2B

Welcome to our comprehensive FAQ page, your go-to resource for answers to all your inquiries about our wide range of cutting-edge products at Alma Lasers LTD.

Filters

OPUS

  • Alma Opus is a plasma and radiofrequency resurfacing platform for face and body, not a laser. It carries two kinds of applicator on one system: thermal RF for patients who want visible improvement with no downtime, and fractional plasma RF for patients who accept a few days of recovery in exchange for a stronger result. That range is why clinics buy it. One platform holds the cautious patient and the ambitious one, treats full-face rejuvenation, fine lines, sagging skin, periorbital laxity and stretch marks, and the combination of both applicators in a single session is where many of the best outcomes come from.

  • In published comparisons of fractional plasma against fractional ablative laser, the clinical results were equivalent and the downtime with Opus was shorter. That does not make CO2 redundant: deep acne scarring and heavy photodamage remain CO2 territory, and Alma sells both platforms. It means that for the large middle of the resurfacing market, texture, fine lines, mild laxity and general rejuvenation, Opus reaches the same endpoint with patients back in circulation sooner. Clinics that own both typically use Opus as the volume resurfacing tool and reserve CO2 for the heavier cases.

  • Yes, and this is one of the main reasons clinics choose it. Because Opus delivers plasma and radiofrequency rather than laser light, the periorbital area is far simpler to treat than on a CO2 platform, where the laser eye-shield workflow makes upper and lower eyelids awkward. Practitioners can work close to the lash line with a cleaner clinical routine. Eyelid and periorbital tightening is one of the most requested treatments in Australian clinics and one of the hardest to deliver well, so this matters commercially as much as clinically.

  • The typical buyer is a doctor and Opus usually lands first in doctor-led clinics, but it is not a doctor-only device. Its protocols are structured enough that, with training and experience, treatment can be delegated to other clinical staff over time, which is what lets a clinic scale the treatment rather than bottleneck it on one practitioner. Because Opus is a plasma and radiofrequency device rather than a laser, the operator rules differ from Class 4 laser rules and vary by state. Alma Lasers Australia takes each clinic through what applies before installation and trains the team on site.

  • Full-face rejuvenation and full resurfacing, fine lines, sagging skin, periorbital and eyelid laxity, and body indications including stretch marks. Face and body applicators run from the same platform. Patients who want no downtime are treated with the thermal RF applicator; patients who accept a few days of recovery for a stronger result are treated with fractional plasma RF, and many protocols combine the two in one session.

  • Visible results are achieved just one treatment, optimal results in 2-3 treatments.

  • The treatment does not require any special skills or a long training time.
    The device is very intuitive to operate.

  • A full-face can be completed with multiple passes in just 10-15 minutes.

  • Faster results with less downtime then ablative laser

  • Yes, Alma’s proprietary Phase Shifter depth control technology enables the user to treat four different depths of tissue, from deep dermis to hypodermis.

  • All instructions appear on guide book supplied with the device. In addition, the Alma local team will be at your service and provide professional support.

  • No, treatment is suitable for versatile skin types and age groups

  • • Skin resurfacing
    • Skin rejuvenation
    • Striae Marks
    • Rhytids and wrinkles
    • Scar treatment including atrophic and hypertrophic scars

  • Proprietary high-frequency energy (40.68 MHz), current is released through pins with high voltage, when in close proximity to the skin, the energy discharges creating plasma resulting in microablative wounds together with a thermal effect.

Loading...